These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

684 related articles for article (PubMed ID: 12867690)

  • 41. Hospital recruitment for the Smallpox Pre-Event Vaccination Program: experiences from Florida, Nebraska, New Jersey, and Tennessee, December 2002-June 2003.
    Ching P; Tynan WP; Raymond D; Bresnitz E; Craig AS
    Public Health Rep; 2004; 119(6):552-6. PubMed ID: 15504446
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vaccines for adults in an age of terrorism.
    Simberkoff MS
    J Assoc Acad Minor Phys; 2002 Jan; 13(1):19-22. PubMed ID: 11852666
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Smallpox: the disease and strategies for its control.
    Walsh M
    Nurs Times; 2002 Dec 17-2003 Jan 6; 98(51):26-7. PubMed ID: 12567874
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Controversy with respect to smallpox vaccination and new vaccination methods].
    Rudkowski Z; Stickl H
    Pediatr Pol; 1974 Mar; 49(3):347-52. PubMed ID: 4150697
    [No Abstract]   [Full Text] [Related]  

  • 45. The use of smallpox virus as a biological weapon: the vaccination situation in France.
    Lévy-Bruhl D; Guérin N;
    Euro Surveill; 2001 Nov; 6(11):171-8. PubMed ID: 11891388
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bioterrorism and smallpox planning: information and voluntary vaccination.
    Selgelid MJ
    J Med Ethics; 2004 Dec; 30(6):558-60. PubMed ID: 15574444
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Economics of cardiac adverse events after smallpox vaccination: lessons from the 2003 US Vaccination Program.
    Ortega-Sanchez IR; Sniadack MM; Mootrey GT
    Clin Infect Dis; 2008 Mar; 46 Suppl 3():S168-78. PubMed ID: 18284356
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Smallpox, bioterrorism, and the neurologist.
    Cleri DJ; Villota FJ; Porwancher RB
    Arch Neurol; 2003 Apr; 60(4):489-94. PubMed ID: 12707060
    [No Abstract]   [Full Text] [Related]  

  • 49. [Smallpox vaccination techniques: considerations and unresolved issues].
    Balicer RD; Davidovitch N; Huerta M; Cohen D; Grotto I
    Harefuah; 2005 Jan; 144(1):51-6, 69. PubMed ID: 15719823
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Can postexposure vaccination against smallpox succeed?
    Mortimer PP
    Clin Infect Dis; 2003 Mar; 36(5):622-9. PubMed ID: 12594644
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Are we heading towards smallpox vaccinations?].
    Leinikki P
    Duodecim; 2003; 119(5):365-7. PubMed ID: 12708237
    [No Abstract]   [Full Text] [Related]  

  • 52. Bioterrorism preparedness--Part II. Smallpox vaccination in a hospital setting.
    Jacobs LM; Emanuelsen K; McKay C; Burns K
    Conn Med; 2004 Jan; 68(1):27-35. PubMed ID: 14752914
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Risks to children of health care personnel receiving smallpox vaccination.
    Cherry JD
    Pediatr Infect Dis J; 2003 Jun; 22(6):574-5. PubMed ID: 12799516
    [No Abstract]   [Full Text] [Related]  

  • 54. Update: adverse events following civilian smallpox vaccination--United States, 2003.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2003 May; 52(19):444-6. PubMed ID: 12807087
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [MVA-vaccine in primovaccination against smallpox after the age of three (author's transl)].
    Schröter W; Stickl H; Idel H; Schlipköter HW
    Zentralbl Bakteriol Mikrobiol Hyg B; 1980 Sep; 171(4-5):309-19. PubMed ID: 7456853
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mouse neurotoxicity test for vaccinia-based smallpox vaccines.
    Li Z; Rubin SA; Taffs RE; Merchlinsky M; Ye Z; Carbone KM
    Vaccine; 2004 Mar; 22(11-12):1486-93. PubMed ID: 15063573
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Smallpox: clinical features, prevention, and management.
    Guharoy R; Panzik R; Noviasky JA; Krenzelok EP; Blair DC
    Ann Pharmacother; 2004 Mar; 38(3):440-7. PubMed ID: 14755066
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Smallpox and smallpox vaccination.
    Lane JM
    N Engl J Med; 2002 Aug; 347(9):691-2; author reply 691-2. PubMed ID: 12200562
    [No Abstract]   [Full Text] [Related]  

  • 59. Enhanced immunogenicity and protective effect conferred by vaccination with combinations of modified vaccinia virus Ankara and licensed smallpox vaccine Dryvax in a mouse model.
    Meseda CA; Garcia AD; Kumar A; Mayer AE; Manischewitz J; King LR; Golding H; Merchlinsky M; Weir JP
    Virology; 2005 Sep; 339(2):164-75. PubMed ID: 15993917
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Update: adverse events following civilian smallpox vaccination--United States, 2003.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2003 May; 52(18):419-20. PubMed ID: 12807092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.